Reuters logo
BRIEF-Cadila Healthcare says Zydus gets final approval from U.S. FDA for ziprasidone hydrochloride capsules
August 23, 2017 / 6:07 AM / in 2 months

BRIEF-Cadila Healthcare says Zydus gets final approval from U.S. FDA for ziprasidone hydrochloride capsules

Aug 23 (Reuters) - Cadila Healthcare Ltd

* Says Zydus receives final approval from USFDA for ziprasidone hydrochloride capsules.

* Says the drug will be manufactured at co’s formulations manufacturing facility at Pharma SEZ, Ahmedabad

* Says drug intended to treat schizophrenia, manic symptoms of bipolar disorder Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below